Microbial Identification Methods Market: Industry Expert View on Future Growth and Market Trends
Microbial identification is the characterization of microbes using a limited spectrum of pre-chosen tests appropriate to the studied problem. Microbial identification results help to decode the root of operational decisions. Therefore, it’s important to use accurate and reproducible microbial identification methods. The widely used methods for microbial identification are phenotypic, genotypic, and proteotypic.
The microbial identification methods market is majorly comprised of top players including Avantor Inc, Becton Dickinson and Co, bioMerieux SA, Merck KGaA, Thermo Fisher Scientific Inc, Bruker Corp, Shimadzu Corp, Accelerate Diagnostics Inc, Molzym GmbH & Co KG, and Biolog Inc.
The companies listed above are implementing various strategies that have resulted in the growth of the company and in turn, have brought about various changes in the worldwide market. Additionally, the companies have adopted several inorganic and organic strategies for accelerating their growth and improving their market position.
About Us:
The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media and Telecommunications, Chemicals and Materials.
The microbial identification methods market is majorly comprised of top players including Avantor Inc, Becton Dickinson and Co, bioMerieux SA, Merck KGaA, Thermo Fisher Scientific Inc, Bruker Corp, Shimadzu Corp, Accelerate Diagnostics Inc, Molzym GmbH & Co KG, and Biolog Inc.
The companies listed above are implementing various strategies that have resulted in the growth of the company and in turn, have brought about various changes in the worldwide market. Additionally, the companies have adopted several inorganic and organic strategies for accelerating their growth and improving their market position.
Below is the list of the growth strategies done by the players operating in the microbial identification methods market:
Jun-2023: Biolog, Inc., announced the launch of the Odin system, an all-in-one cellular phenotyping and microbial identification platform. Odin is compatible with all Biolog assays
April-2023: Bruker Corporation launched the fast next-generation MALDI Biotyper IVD Software and optimized MBT Mycobacteria IVD Kit and MBT HT Filamentous Fungi IVD Module. The launch is expected to complement company's user-friendly, best-in-class diagnostic solutions for routine clinical microbiology and infection diagnostics laboratories
Jul-2022: Accelerate Diagnostics Inc announced CE marking of its new Accelerate Arc Module and BC kit. Designed for labs with MALDI platforms, the Accelerate Arc Module and BC kit is a novel application of inline centrifugation and automated sample prep techniques, which together with the blood culture (BC) kit, provides a suspension of cleaned microbial cells for direct transfer to a MALDI spotting plate
Jan-2022: BD received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the BD Kiestra IdentifA system, designed to automate microbiology bacterial identification testing preparation
Sep-2021: Avantor announced a global distribution agreement with Oxford Nanopore Technologies, a market leading manufacturer of Next Generation Sequencing instruments, kits, and consumables. The agreement enables scientists to have broader access to Oxford Nanopore’s portable real-time nanopore sequencing device, MinION, associated consumables and reagents.
Jun-2023: Biolog, Inc., announced the launch of the Odin system, an all-in-one cellular phenotyping and microbial identification platform. Odin is compatible with all Biolog assays
April-2023: Bruker Corporation launched the fast next-generation MALDI Biotyper IVD Software and optimized MBT Mycobacteria IVD Kit and MBT HT Filamentous Fungi IVD Module. The launch is expected to complement company's user-friendly, best-in-class diagnostic solutions for routine clinical microbiology and infection diagnostics laboratories
Jul-2022: Accelerate Diagnostics Inc announced CE marking of its new Accelerate Arc Module and BC kit. Designed for labs with MALDI platforms, the Accelerate Arc Module and BC kit is a novel application of inline centrifugation and automated sample prep techniques, which together with the blood culture (BC) kit, provides a suspension of cleaned microbial cells for direct transfer to a MALDI spotting plate
Jan-2022: BD received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the BD Kiestra IdentifA system, designed to automate microbiology bacterial identification testing preparation
Sep-2021: Avantor announced a global distribution agreement with Oxford Nanopore Technologies, a market leading manufacturer of Next Generation Sequencing instruments, kits, and consumables. The agreement enables scientists to have broader access to Oxford Nanopore’s portable real-time nanopore sequencing device, MinION, associated consumables and reagents.
The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media and Telecommunications, Chemicals and Materials.
Comments
Post a Comment